Nanjing Vishee Medical Technology Co (SHSE:688580) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688580 Nanjing Vishee Medical Technology Co Ltd SHSE:688580
91 GF Score
Price ¥49.10
GF Value ¥54.76
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nanjing Vishee Medical Technology Co FFO per Share?

FFO per Share only applies to REITs.

SHSE:688580
91GF Score
Nanjing Vishee Medical Technology Co Ltd SHSE:688580
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nanjing Vishee Medical Technology Co (SHSE:688580) Overvalued in 2026?

Based on GuruFocus' analysis, Nanjing Vishee Medical Technology Co stock appears to be undervalued. The current stock price of ¥49.10 is trading 10.3% below its estimated GF Value™ of ¥54.76. GuruFocus considers Nanjing Vishee Medical Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:688580:

  • FFO per Share:
  • GF Value™: ¥54.76 vs. price of ¥49.10 (10.3% below fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688580 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nanjing Vishee Medical Technology Co Business Description

Address No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
91GF Score

Get the complete analysis for SHSE:688580

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥49.10
Price
¥54.76
GF Value